04/09/2026
There is a name to what is happening to your joints in perimenopause and many doctors in specialties outside of women’s health haven’t heard the term yet.
In 2024, researchers formally named the Musculoskeletal Syndrome of Menopause, which is a collective term for the bone, joint, muscle, and connective tissue changes that accompany the drop in estrogen during the menopausal transition.
This isn’t new and the correlation between menopause and MSK degeneration has been acknowledged for decades. What’s new is the language and the recognition that these symptoms deserve to be treated as a coherent syndrome, not a scattered list of complaints.
Typical symptoms include:
— Joint pain that moves around or fluctuates
— Stiffness that appeared without an obvious cause
— Tendons that suddenly don’t tolerate what they used to
— Accelerating bone loss
— Muscle mass that’s harder to maintain
Estrogen receptors are found throughout the musculoskeletal system(joint cartilage, tendons, ligaments, and bone). When estrogen fluctuates and eventually drops, it becomes a systemic issue.
An estimated 70% of women in perimenopause will experience MSK symptoms. 25% will be significantly disabled by them through the transition.
Joint pain during this transition is not just aging and there is SO much we can do together to prevent and treat early decline.